Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hutchison China Meditech

15.20
-0.1400-0.91%
Volume:5.63K
Turnover:85.23K
Market Cap:2.65B
PE:76.00
High:15.28
Open:15.10
Low:14.86
Close:15.34
Loading ...

Is Petrobras (PBR) the Ridiculously Cheap Stock to Invest in?

Insider Monkey
·
20 Apr

Is Weibo Corporation (WB) the Ridiculously Cheap Stock to Invest in?

Insider Monkey
·
20 Apr

Is Diversified Energy Company (DEC) the Ridiculously Cheap Stock to Invest in?

Insider Monkey
·
20 Apr

Is Invesco Mortgage Capital (IVR) the Ridiculously Cheap Stock to Invest in?

Insider Monkey
·
20 Apr

Asure Software to Announce First Quarter 2025 Financial Results on May 1, 2025

GlobeNewswire
·
18 Apr

Dayforce to Announce First Quarter 2025 Financial Results on May 7th and Participate in Upcoming Investor Conferences

GlobeNewswire
·
16 Apr

Bristol Myers says Phase 3 ODYSSEY-HCM Camzyos trial did not meet endpoints

TIPRANKS
·
15 Apr

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial

Business Wire
·
15 Apr

Paychex Completes Acquisition of Paycor

Business Wire
·
14 Apr

Engineering and Construction Companies Lay the Groundwork for Growth and Innovation with Oracle Fusion Cloud Applications

PR Newswire
·
10 Apr

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

Zacks
·
10 Apr

Tampa Bay Buccaneers Expand Dayforce Partnership

GlobeNewswire
·
09 Apr

3 Internet Delivery Services Stocks in Focus Amid Industry Challenges

Zacks
·
08 Apr

Is Workday Inc. (WDAY) the Best Enterprise Software Stock to Buy Now?

Insider Monkey
·
06 Apr

Edgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your Money

Insider Monkey
·
06 Apr

Analysts Expect Breakeven For Asure Software, Inc. (NASDAQ:ASUR) Before Long

Simply Wall St.
·
04 Apr

Safe Harbor Financial and Würk Partner to Expand Access to Cannabis Financial Services and Workforce Solutions

GlobeNewswire
·
03 Apr

Cytokinetics: A Promising Investment with Aficamten’s Competitive Edge in HCM Treatment

TIPRANKS
·
03 Apr

Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting

GlobeNewswire
·
31 Mar

Why Cytokinetics, Incorporated (CYTK) Is the Best Mid Cap Biotech Stock to Buy

Insider Monkey
·
31 Mar